The American pharmaceutical company Pfizer announced today that its antiviral vaccine has provided strong resistance to covid during research among children between the ages of 12 and 15.
Photo: Depositphotos / Belchonock
The two doses of Pfizer were 100 percent effective against kovid, based on measurements made four months after the second dose, the company said, Reuters reports.
Pfizer plans to apply for full vaccine approval in this age group, in the United States and around the world after long-term data.
Pfizer and Biontech are seeking approval for a dose of 30 micrograms, for children 12 years of age and older.
To date, the vaccine has been approved by the U.S. Food and Drug Administration, but only for emergency use between the ages of 12 and 15, while a full permit has been issued. given for people 16 years and older.